Choose the next step

The correction formula has already done its job and cannot do more. The question in front of you is what specimen or repeat test would most directly resolve whether this patient's physiologically active calcium is actually low, given hypoalbuminemia and a PTH that does not fit a fully-corrected calcium.

Ionized calcium, collected anaerobically and analyzed within the local assay procedure’s validated window; an exceeded window makes the specimen unsuitable, measures the active fraction directly rather than estimating it, and it is specifically preferred over the correction formula in states like hypoalbuminemia where the formula is known to perform poorly. Recalculating the correction with a different albumin reference value does not add new information: it is still an estimate of total calcium, not a measurement of ionized calcium. Repeating total calcium again on the same specimen the next day does not address the physiologic question either, and repeating only PTH on a different assay generation without reassessing calcium abandons the more direct measurement in favor of a result that is not comparable to the first one.

It is just as important to resist a premature label. Primary hyperparathyroidism, by the Fourth International Workshop framework, rests on persistent hypercalcemia with a PTH concentration that is frankly elevated or inappropriately not suppressed for the calcium level; that framework explicitly requires excluding vitamin D deficiency, reduced kidney function, and other secondary causes before that diagnosis is entertained. This case has a low, not high, total calcium and a low 25(OH)D that has not been excluded as a driver; calling it primary hyperparathyroidism from PTH alone skips exactly the exclusion step the diagnostic framework requires.

When a bedside formula and a hormone result disagree, order the test that measures the disputed variable directly, and hold off naming a diagnosis until the more direct result is in hand.